manual-prevencion

MANUAL SEOM DE PREVENCIÓN Y DIAGNÓSTICO PRECOZ DEL CÁNCER 218 1. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. ARCI: OMS. http://globocan.iarc . fr/Default.aspx 2. Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C. European Society for Medical Oncology (ESMO) GuidelinesWorking Group. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 (suppl_6):vi 24-32. 3. Chen L, Berek JS. Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Epidemiology and risk factors. UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, 2016. http://www.uptodate.com 4. DynaMed Plus [Internet]. Ipswich (MA): EBSCO Information Services. 1995. Record No. 900705, Ovarian cancer [about 59 screens]. http://www.dynamed.com 5. Carlson KJ. Screening for ovarian cancer. UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, 2016. http://www.uptodate.com 6. Buys S. Effect of screening on ovarian cancer mortality. The prostate, lung, colorectal and ovarian cancer screening randomized trial. JAMA. 2011;305 (22):2295-303. 7. Jacobs I, Menon U, Ryan A, Gentry-Maharaj A, Burnell, M, Kalsi JK et. al. Ovarian cancer screening and mortality in UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomized controlled trial. The Lancet. 2016;387: 945-56. 8. Kobayashi H, Yamada Y, Sado T, et. al. A randomized study of screening for ovarian cancer: a multicenter study in Japan. Int J Gynecol Cancer. 2008;18: 414-20. 9. Oaknin A et al. SEOM guidelines for endometrial cancer. Clin Transl Oncol. 2012; 14:512-515. 10. National Cancer Institute. Endometrial cancer treatment Physician Data Query.2015. http://www.cancer.gov/cancertopics/ pdq/treatment/endometrial/healthprofessional 11. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report. Food, Nutrition, Physical Activity, and the prevention Of Endometrial Cancer. 2013. htt://www.dietandcancerreport.org . 12. Lancanster JM, Powell CB, Chen LM, Richardson DL. Society of Gynecologic Oncology Statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol. 2015;136:3-7. 13. DynaMed Plus [Internet]. Ipswich (MA): EBSCO Information Services. 1995. Record No. 113952, Endometrial cancer; [about 40 screens]. http://www.dynamed.com 14. Colombo N, Creutzberg C., Amant F., Bosse T., González-Martín A., Ledermann J., et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Annals of Oncology. 2016;27:16-41. 15. Frumovitz M. Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations and diagnosis. UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, 2017. http://www.uptodate.com 16. Shepherd JP, Frampton GK, Harris P. Interventions for encouraging sexual behaviours intended to prevent cervical cancer. Cochrane Database Syst Rev. 2011;(4):CD001035. 17. Winer RL, Hughes JP, Feng Q, O’Reilly S, Kiviat NB, Holmes KK, Koutsky LA. Condom use and the risk of genital human papillomavirus infection in Young women. N Engl J Med. 2006 Jun 22;354(25):2645-54. 18. J Thomas Cox, MD, Joel M Palefsky, MD. Recommendations for the use of human papillomavirus vaccines. UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, 2017. http://www.uptodate.com 19. Wheeler CM, Skinner SR, Del Rosario-Raymundo MR, Garland SM, Chatterjee A, Lazcano-Ponce E, et al. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow- up of the phase 3, double-blind, randomised controlled VIVIANE study. Lancet Infect Dis. 2016;16: 1154–1168. 20. Marzo-Castillejo M, Bellas-Beceiro B, Vela-Vallespín C, Nuin-Villanueva M, Bartolomé-Moreno C, Melús-Palazón E, et al. Recomendaciones de prevención del cáncer. Actualización 2016. Aten Primaria. 2016 Jun;48 Suppl 1:39-59. 21. “Oncoguía SEGO: Prevención del cáncer de cuello de útero. Guías de práctica clínica en cáncer ginecológico y mamario. Publicaciones SEGO, Octubre 2014. Webs recomendadas: 1. U.S. Preventive Services Task Force (USPST). http://www.uspreventiveservicestask force.org/ 2. Canadian Task Force on Preventive Health Care. http://www.canadiantaskforce.ca/ 3. National Institute for Health and Care Excellence (NICE). https://www.nice.org.uk 4. Para la clasificación de la evidencia científica y la fuerza de las recomendaciones se ha utilizado el sistema GRADE (Grading of Recommendations Assessment, Development and EvaluationWorking Group). http://www.gradeworkinggroup.org/